[1]乔文礼,赵晋华.18F-氟脱氧葡萄糖PET在靶区确定和放疗计划制定中的价值[J].国际放射医学核医学杂志,2007,31(6):345-349.
 QIAO Wen-li,ZHAO Jin-hua.18F-fluorodeoxyglucose PET in definition of target volumes and radiotherapy treatment planning[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(6):345-349.
点击复制

18F-氟脱氧葡萄糖PET在靶区确定和放疗计划制定中的价值(/HTML)
分享到:

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
31
期数:
2007年第6期
页码:
345-349
栏目:
临床核医学
出版日期:
1900-01-01

文章信息/Info

Title:
18F-fluorodeoxyglucose PET in definition of target volumes and radiotherapy treatment planning
作者:
乔文礼 赵晋华
200080 上海, 上海交通大学附属第一人民医院核医学科
Author(s):
QIAO Wen-li ZHAO Jin-hua
Department of Nuclear Medicine, The First People’s Hospital, Shanghai Jiaotong University, Shanghai 200080, China
关键词:
体层摄影术发射型计算机氟脱氧葡萄糖F18放射治疗计划计算机辅助
Keywords:
Tomographyemission-computedFluorodeoxyglucoseF 18Radiotherapy planningcomputer-assisted
分类号:
R814.42;R817.4
摘要:
PET是一种功能性影像技术,能够提供丰富的肿瘤生物学信息,在肿瘤靶区确定和放疗计划制定中有其应用空间。18F-氟脱氧葡萄糖(18F-FDG)具有高度的敏感性和特异性,在非小细胞肺癌、头颈部鳞状细胞癌、食管癌确定放疗靶区和制定放疗计划时具有较大作用,但尚缺乏在直肠癌等肿瘤靶区确定中的价值的相关研究。18F-FDG PET应用于放射治疗在很多方面存在问题,能否作为制定放疗计划的标准,尚无大量前瞻性临床研究,有待进一步研究和证实。
Abstract:
PET is a functional imaging modality, which can give some biological information of tumor. PET is more and more important in the definition of target volumes and radiotherapy treatment planning. Depending on its sensitivity and specificity, 18F-fluorideoxyglucose 18F-FDG PET has been shown to influence the selection of target vofumes and radiotherapy treatment planning for non-small cell lung cancers, for head and neck squamous cell carcinomas or for esophageal tumors. On the other hand, for tumors such as rectal carcinomas, convincing data on the value of 18F-FDG PET for target volume selection are still lacking. However, the application of 18F-FDG PET in many aspects of radiotherapy is still controversy. Further researches in its clinical application are still needed to investigate whether 18F-FDG PET for treatment planning should be routine because of the lack of prospective studies.

参考文献/References:

1 司宏伟,耿建华,陈盛祖.PET-CT在调强适形放疗中的临床应用.国外医学·放射医学核医学分册,2005,29(5):223-226.
2 Gregoire V, Haustermans K, Geets X, et al. PET-based treatment planning in radiotherapy:a new standard?. J Nucl Med, 2007, 48(Suppl 1):68S-77S.
3 Messa C, Di Muzio N, Picchio M, et al. PET/CT and radiotherapy. Q J Nucl Med Mol Imaging, 2006, 50(1):4-14.
4 Nestle U, Walter K, Schmidt S, et al.18F-Deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer:high impact in patients with atelectasis. Int J Radiat Oncol Biol Phys, 1999, 44(3):593-597.
5 Erdi YE, Rosenzweig K, Erdi AK, et al. Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET). Radiother Oncol, 2002, 62(1):51-60.
6 De Ruysscher D, Wanders S, van Haren E, et al. Selective mediastinal node irradiation based on FDG-PET scan data in patients with nonsmall-cell lung cancer:a prospective clinical study. Int J Radiat Oncol Biol Phys, 2005, 62(4):988-994.
7 MacManus MP, Hicks RJ, Matthews JP, et al. High rate of detection of unsuspected distant metastases by PET in apparent stage Ⅲ nonsmall-cell lung cancer:implications for radical radiation therapy. Int J Radiat Oncol Biol Phys, 2001, 50(2):287-293.
8 Gondi V, Bradley K, Mehta M, et al. Impact of hybrid fluorodeoxyglucose positron-emission tomography/computed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer. Int J Radiat Oncol Biol Phys, 2007, 67(1):187-195.
9 Deniaud-Alexandre E, Touboul E, Lerouge D, et al. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys, 2005, 63(5):1432-1441.
10 van Der Wel A, Nijsten S, Hochstenbag M, et al. Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3MO non-small-cell lung cancer:a modeling study. Int J Radiat Oncol Biol Phys, 2005, 61(3):649-655.
11 Yaremko B, Riauka T, Robinson D, et al. Threshold modification for tumour imaging in non-small-cell lung cancer using positron emission tomography. Nucl Med Commun, 2005, 26(5):433-440.
12 Biehl KJ, Kong FM, Dehdashti F, et al. 18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer:is a single standardized uptake value threshold approach appropriate. J Nucl Med, 2006, 47(11):1808-1812.
13 Geets X, Daisne JF, Gregoire V, et al. Role of 11-C-methionine positron emission tomography for the delineation of the tumor volume in pharyngo-laryngeal squamous cell carcinoma:comparison with FDG-PET and CT. Radiother Oncol, 2004, 71(3):267-273.
14 Ciernik IF, Dizendorf E, Baumert BG, et al. Radiation treatment planning with an integrated positron emission and computer tomography(PET/CT):a feasibility study. Int J Radiat Oncol Biol Phys, 2003, 57(3):853-863.
15 Paulino AC, Koshy M, Howell R, et al. Comparison of CT-and FDGPET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys, 2005, 61(5):1385-1392.
16 Gregoire V, Daisne JF, Geets X. Comparison of CT-and FDG-PETdefined GT:in regard to Paulino et al. (Int J Radiat Oncol Biol Phys 2005;61:1385-1392). Int J Radiat Oncol Biol Phys, 2005, 63(1):308-309.
17 Daisne JF, Sibomana M, Bol A, et al. Tri-dimensional automatic segmentation of PET volumes based on measured source-tobackground ratios:influence of reconstruction algorithms. Radiother Oncol, 2003, 69(3):247-250.
18 Rahn AN, Baum RP, Adamietz IA, et al. Value of 18F -fluorodeoxyglucose positron emission tomography in radiotherapy planning of headneck tumors. Strahlenther Onkol, 1998, 174(7):358-364.
19 Schwartz DL, Ford E, Rajendran J, et al. FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys, 2005, 61(1):129-136.
20 Schwartz DL, Ford EC, Rajendran J, et al. FDG-PET/CT-guided intensity modulated head and neck radiotherapy:a pilot investigation. Head Neck, 2005, 27(6):478-487.
21 Moureau-Zabotto L, Touboul E, Lerouge D, et al. Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma. Int J Radiat Oncol Biol Phys, 2005, 63(2):340-345.
22 Vrieze O, Haustermans K, De Wever W, et al. Is there a role for FDG-PET in radiotherapy planning in esophageal carcinoma?. Radiother Oncol, 2004, 73(3):269-275.
23 Leong T, Everitt C, Yuen K, et al. A prospective study to evaluate the impaet of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer. Radiother Oncol, 2006, 78(3):254-261.
24 Howard A, Mehta MP, Ritter MA, et al. The value of PET/CT in gross tumor volume delineation in lung and esophagus cancer. Int J Radiat Oncol Biol Phys, 2004, 60(Suppl):S536-S537.
25 Ciernik IF, Huser M, Burger C, et al. Automated functional imageguided radiation treatment planning for rectal cancer. Int J Radiat Oncol Biol Phys, 2005, 62(3):893-900.

相似文献/References:

[1]周玉祥,蓝博文,黄春榆,等.64排螺旋CT冠状动脉血管成像诊断冠状动脉-肺动脉瘘的应用价值[J].国际放射医学核医学杂志,2016,40(1):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
 Zhou Yuxiang,Lan Bowen,Huang Chunyu,et al.Clinical value of coronary artery-pulmonary artery fistula revealed by 64-slice spiral CT coronary angiography[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
[2]陈超坤,刘亮,傅飞先,等.囊性胸腺瘤和囊性畸胎瘤的影像学特征及鉴别诊断[J].国际放射医学核医学杂志,2016,40(1):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
 Chen Chaokun,Liu Liang,Fu Feixian,et al.Imaging features and differential diagnosis of cystic thymoma and cystic teratoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
[3]岳进,苏丽萍.全身MRI与PET/CT在淋巴瘤骨髓浸润诊断及预后中的作用[J].国际放射医学核医学杂志,2016,40(1):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
 Yue Jin,Su Lipin.Function of whole-body MRI and PET/CT in the diagnosis and prognosis of lymphoma with bone marrow infiltration[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
[4]张莹莹,王振光,孔艳.PET/CT显像在肺间质纤维化中的应用进展[J].国际放射医学核医学杂志,2016,40(1):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
 Zhang Yingying,Wang Zhenguang,Kong Yan.Application advancement on PET/CT in pulmonary interstitial fibrosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
[5]麦卫平,张永林.能谱CT成像在肺癌诊断中的应用研究进展[J].国际放射医学核医学杂志,2016,40(1):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
 Mai Weiping,Zhang Yonglin.Research progress of spectral imaging in the diagnosis of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
[6]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
 Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
[7]周翠屏,廖俊杰,何国华,等.原发性肠系膜巨大淋巴结增生症的MSCT表现与病理对照分析[J].国际放射医学核医学杂志,2016,40(3):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
 Zhou Cuiping,Liao Junjie,He Guohua,et al.Primary mesenteric Castleman disease:MSCT findings with histopathologic correlation[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
[8]张巧娜,刘汉东.上颌窦上皮-肌上皮癌的CT表现一例[J].国际放射医学核医学杂志,2016,40(3):237.[doi:10.3760/cma.j.issn.1673-4114.2016.03.015]
[9]尤阳,轩昂,张杰,等.淋巴瘤患者大脑静息葡萄糖代谢改变[J].国际放射医学核医学杂志,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
 You Yang,Xuan Ang,Zhang Jie,et al.Changes in resting-state brain glucose metabolism in patients with lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
[10]王朋,崔邦平,代文莉,等.18F-FDG PET/CT在前列腺癌中的应用进展[J].国际放射医学核医学杂志,2016,40(4):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
 Wang Peng,Cui Bangping,Dai Wenli,et al.Progress in the application of 18F-FDG PET/CT in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
[11]陈立,陈跃.分化型甲状腺癌骨转移诊断及疗效评价的核素显像研究进展[J].国际放射医学核医学杂志,2016,40(6):452.[doi:10.3760/cma.j.issn.1673-4114.2016.06.010]
 Chen Li,Chen Yue.Diagnosis and evaluation of curative effect progress of radionuclide imaging methods in differentiated thyroid cancer of bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):452.[doi:10.3760/cma.j.issn.1673-4114.2016.06.010]
[12]安淑娴,宋少莉,黄钢.放射性核素标记的凋亡显像剂的研究进展[J].国际放射医学核医学杂志,2015,39(6):470.[doi:10.3760/cma.j.issn.1673-4114.2015.06.008]
 An Shuxian,Song Shaoli,Huang Gang.Recent advances in apoptosis imaging using radionuclide-labeled tracers[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):470.[doi:10.3760/cma.j.issn.1673-4114.2015.06.008]
[13]陶绪长,罗晓文,关晏星.阿德福韦酯所致低血磷性骨软化症治疗前后SPECT骨显像对比一例[J].国际放射医学核医学杂志,2015,39(6):513.[doi:10.3760/cma.j.issn.1673-4114.2015.06.018]
 [J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):513.[doi:10.3760/cma.j.issn.1673-4114.2015.06.018]
[14]成钊汀,朱小华.99Tcm-MIBI显像在甲状旁腺功能亢进症中的应用及进展[J].国际放射医学核医学杂志,2015,39(1):37.[doi:10.3760/cma.j.issn.1673-4114.2015.01.009]
 Cheng Zhaoting,Zhu Xiaohua.Application and progress of 99Tcm-MIBI scintieraphy in parathyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):37.[doi:10.3760/cma.j.issn.1673-4114.2015.01.009]
[15]林潇,唐明灯.靶向表皮生长因子受体分子探针研究进展[J].国际放射医学核医学杂志,2015,39(1):85.[doi:10.3760/cma.j.issn.1673-4114.2015.01.018]
 Lin Xiao,Tang Mingdeng.Research progresses on molecular probes targeting epidermal growth factor receptor[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):85.[doi:10.3760/cma.j.issn.1673-4114.2015.01.018]
[16]刘晓梅,张芳,黄建敏.肿瘤血管生成的SPECT分子显像研究进展[J].国际放射医学核医学杂志,2015,39(2):170.[doi:10.3760/cma.j.issn.1673-4114.2015.02.015]
 Liu Xiaomei,Zhang Fang,Huang Jianmin.Research advance on molecular imaging of tumor angiogenesis with SPECT[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):170.[doi:10.3760/cma.j.issn.1673-4114.2015.02.015]
[17]刘晋华,张宝牛,赵德善.盆腔融合异位肾一例[J].国际放射医学核医学杂志,2015,39(2):190.[doi:10.3760/cma.j.issn.1673-4114.2015.02.020]
[18]陈明,刘纯,严祥,等.SPECT胃黏膜显像在胃中间横带研究中的价值[J].国际放射医学核医学杂志,2015,39(3):197.[doi:10.3760/cma.j.issn.1673-4114.2015.03.002]
 Chen Ming,Liu Chun,Yan Xiang,et al.The value of gastric mucosa SPECT in the study of midgastric transverse band[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):197.[doi:10.3760/cma.j.issn.1673-4114.2015.03.002]
[19]刘雪辉,李洪均,于鸿煦.SPECT/CT融合显像对可疑骨转移灶的诊断效能[J].国际放射医学核医学杂志,2015,39(3):201.[doi:10.3760/cma.j.issn.1673-4114.2015.03.003]
 Liu Xuehui,Li Hongjun,Yu Hongxu.Diagnostic efficacy of SPECT/CT fusion imaging in assessing possible bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):201.[doi:10.3760/cma.j.issn.1673-4114.2015.03.003]
[20]郭宵峰,刘建中,孙琦婷.肺通气/灌注平面显像与肺灌注SPECT/CT对肺栓塞诊断价值的对比性研究[J].国际放射医学核医学杂志,2015,39(4):277.[doi:10.3760/cma.j.issn.1673-4114.2015.04.001]
 Guo Xiaofeng,Liu Jianzhong,Sun Qiting.Comparative study of pulmonary ventilation/perfusion planar imaging and pulmonary perfusion SPECT combined with low-dose CT in the diagnosis of pulmonary embolism[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):277.[doi:10.3760/cma.j.issn.1673-4114.2015.04.001]

备注/Memo

备注/Memo:
收稿日期:2007-09-10。
通讯作者:赵晋华,E-mail:zjhl963@gmail.com
更新日期/Last Update: 1900-01-01